feed,title,long_url,short_url
Benzinga,Yumanity Therapeutics Sees Lead Candidate Interim Data From Early-Stage Parkinson's Study By Mid-2021,https://www.benzinga.com/general/biotech/21/02/19590800/yumanity-therapeutics-sees-lead-candidate-interim-data-from-early-stage-parkinsons-study-by-mid-2,https://j.mp/3p3TGqF
